Hormone pretreatment before frozen embryo transfer for adenomyosis
Part of Women’s health & pregnancy clinical trials.
This study tests whether using a hormone medication (GnRH agonist) before a frozen embryo transfer helps women with adenomyosis. If you have adenomyosis and are planning a frozen embryo transfer, this trial will help compare results with or without the pre-treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of adenomyosis (by ultrasound or MRI).
- You are between 18 and 42 years old.
- You have had 3 or fewer previous IVF cycles.
- You plan to use frozen embryos for this transfer.
- You agree to have no more than 2 day-3 embryos or 1 blastocyst transferred.
- You have not had a GnRH injection in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether frozen embryo transfer (placing a previously frozen embryo in the uterus) is effective for women with adenomyosis (a condition where uterine tissue grows into the uterine wall). It may help improve pregnancy chances for women with this condition.
This trial studies whether giving a GnRH “downshifting” shot before transferring a frozen embryo can improve pregnancy outcomes for people with endometriosis or adenomyosis. It may help by changing hormone activity before the transfer.
This study tests if treating immune system factors can help women with adenomyosis who are having trouble getting pregnant. It aims to see if addressing these immune aspects improves pregnancy chances.
This study uses advanced imaging and lab tests to better diagnose endometriosis and adenomyosis. Participants must be of European descent, have a clear ultrasound diagnosis, and be undergoing IVF (in vitro fertilization) — specifically a first or second cycle if they have both conditions, or a frozen embryo transfer if they have just one.
This early-stage study tests a new treatment for adenomyosis, a condition that can cause heavy bleeding and pelvic pain. The goal is to find a way to ease these symptoms, and it may be an option if you are between 30 and 50, have adenomyosis, and are not planning to become pregnant.
This study looks at how well different methods (clinical exams, imaging, and tissue analysis after surgery) can diagnose adenomyosis. It is for women who have heavy bleeding and pain, have completed their families, and have decided to have a hysterectomy.
Hear when a new Adenomyosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.